{ "run": { "id": "cmnr14okt05bcp658epo0ohse", "region": "US", "assetId": "cmnr14oim05b8p658jwabmkl9", "ticker": "NDSN", "snapshotId": "cmnr14oj205bap658etq5t8ep", "promptTemplateId": "cmnqt07si0005lm3jzpxuu1ux", "createdAt": "2026-04-09T05:21:28.683Z", "promptTemplate": { "id": "cmnqt07si0005lm3jzpxuu1ux", "name": "Oficial 08.apr.2026", "version": 1 }, "snapshot": { "id": "cmnr14oj205bap658etq5t8ep", "assetId": "cmnr14oim05b8p658jwabmkl9", "asOf": "2026-04-08T20:00:00.000Z", "snapshot": { "asOf": "2026-04-08T20:00:00.000Z", "quote": { "asOf": "2026-04-08T20:00:00.000Z", "open": null, "price": 274.57, "dayLow": 273.2, "volume": 384847, "dayHigh": 277.387, "currency": "USD", "prevClose": 265.47, "week52Low": 165.03, "week52High": 305.28 }, "fundamentals": { "pe": 27.0969626168224, "beta": 0.965400685535918, "epsTTM": 8.56, "fcfTTM": 667604000, "growth": { "epsYoy": 0.04773561811505515, "revenueYoy": -0.7601948212675704 }, "sector": "General Industrial Machinery & Equipment, NEC", "margins": { "net": 0.1176460327188723, "gross": 0.1399594549997643, "operating": 0.1647942105511291 }, "website": "http://nordson.com", "industry": null, "pegRatio": 5.67646627126766, "ebitdaTTM": 815830000, "forwardPe": 20.6913470115968, "marketCap": 10705289437, "totalCash": 120392000, "totalDebt": 2038363000, "debtEquity": 0.759388888907142, "quickRatio": 1.504133255370623, "revenueTTM": 2121100000, "companyName": "NORDSON CORP", "priceToBook": 2.54481301293304, "currentRatio": 2.720734095715891, "dividendYield": 0.0136384044197847, "returnOnAssets": 0.04186248368960372, "returnOnEquity": 0.159179463860051, "analystOpinions": null, "businessSummary": "Nordson Corporation is an American multinational corporation that designs and manufactures dispensing equipment for consumer and industrial adhesives, sealants and coatings. The company also manufactures equipment used in the testing and inspection of electronic components, technology-based systems for curing and surface treatment processes as well as medical devices and component technologies. The company is headquartered in Westlake, Ohio, and has direct operations and sales-support offices in approximately 30 countries.", "enterpriseValue": 15332573700, "analystTargetLow": null, "analystTargetHigh": null, "analystTargetMean": null, "fullTimeEmployees": 8000, "sharesOutstanding": 55783598, "enterpriseToEbitda": 18.79383413211086, "analystTargetMedian": null, "enterpriseToRevenue": 7.228595398613927, "operatingCashflowTTM": 140428000, "analystRecommendationKey": null } }, "createdAt": "2026-04-09T05:21:28.623Z" }, "results": [ { "id": "cmnr14okw05bep65818xie5k5", "runId": "cmnr14okt05bcp658epo0ohse", "modelId": "anthropic", "status": "SUCCESS", "rawOutput": "{\"model\":\"ai-equity-research-v1\",\"as_of\":\"2026-04-08T20:00:00.000Z\",\"ticker\":\"NDSN\",\"currency\":\"USD\",\"current_price\":274.57,\"target_price_6m\":280,\"target_price_12m\":285,\"recommendation\":\"HOLD\",\"confidence\":0.58,\"thesis_bullets\":[\"Quality industrial compounder with 59+ year dividend growth streak\",\"Elevated PEG ratio of 5.7x signals limited near-term growth for valuation\",\"Revenue roughly flat YoY while EPS grew ~5% on margin discipline\",\"Significant debt load (~$2B) from acquisitions limits balance sheet flexibility\",\"Valuation at ~27x trailing P/E appears full given low-single-digit growth\"],\"key_drivers\":[{\"driver\":\"End-market recovery in electronics and industrial spending\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Acquisition integration (ARAG and prior deals) synergy realization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Pricing power in niche precision dispensing markets\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Macro/industrial slowdown dampening organic growth\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Elevated leverage constraining capital deployment optionality\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Dividend growth track record supporting investor base\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Foreign exchange headwinds from strong USD\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Medical & fluid solutions segment providing defensive growth\",\"impact\":\"MED\",\"direction\":\"POS\"}],\"risks\":[\"Prolonged industrial capex downturn compresses earnings and multiples\",\"Debt service burden increases if rates stay elevated longer\",\"Integration risk from recent acquisitions dilutes returns on capital\",\"Customer destocking cycles in adhesives/coatings end-markets\",\"Tariff/trade policy disruption to global supply chain\"],\"assumptions\":{\"revenue_cagr_3y\":0.04,\"ebit_margin_target\":0.25,\"wacc\":0.095,\"terminal_multiple\":18},\"scenarios\":{\"bear\":{\"target_price\":220,\"prob\":0.2,\"notes\":\"Industrial recession, margin compression, multiple de-rating to ~15x EBITDA.\"},\"base\":{\"target_price\":285,\"prob\":0.55,\"notes\":\"Low-single-digit organic growth, stable margins, multiple holds near 18-19x EBITDA.\"},\"bull\":{\"target_price\":330,\"prob\":0.25,\"notes\":\"End-market recovery, synergy upside, multiple re-rates toward 21x EBITDA.\"}},\"method_notes\":\"Blended EV/EBITDA and forward P/E approach. Snapshot gross margin (14%) appears anomalous vs historical (~55%); used snapshot values per rules but normalized EBIT margin assumption at 25% for forward modeling. At ~27x trailing P/E and PEG >5x, valuation looks full relative to low-single-digit growth. 12M base target implies ~3.8% return, within HOLD band. Probability-weighted scenario value ~$282, consistent with modest upside. Not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:00.000Z", "model": "ai-equity-research-v1", "risks": [ "Prolonged industrial capex downturn compresses earnings and multiples", "Debt service burden increases if rates stay elevated longer", "Integration risk from recent acquisitions dilutes returns on capital", "Customer destocking cycles in adhesives/coatings end-markets", "Tariff/trade policy disruption to global supply chain" ], "ticker": "NDSN", "currency": "USD", "scenarios": { "base": { "prob": 0.55, "notes": "Low-single-digit organic growth, stable margins, multiple holds near 18-19x EBITDA.", "target_price": 285 }, "bear": { "prob": 0.2, "notes": "Industrial recession, margin compression, multiple de-rating to ~15x EBITDA.", "target_price": 220 }, "bull": { "prob": 0.25, "notes": "End-market recovery, synergy upside, multiple re-rates toward 21x EBITDA.", "target_price": 330 } }, "confidence": 0.58, "assumptions": { "wacc": 0.095, "revenue_cagr_3y": 0.04, "terminal_multiple": 18, "ebit_margin_target": 0.25 }, "key_drivers": [ { "driver": "End-market recovery in electronics and industrial spending", "impact": "HIGH", "direction": "POS" }, { "driver": "Acquisition integration (ARAG and prior deals) synergy realization", "impact": "MED", "direction": "POS" }, { "driver": "Pricing power in niche precision dispensing markets", "impact": "MED", "direction": "POS" }, { "driver": "Macro/industrial slowdown dampening organic growth", "impact": "HIGH", "direction": "NEG" }, { "driver": "Elevated leverage constraining capital deployment optionality", "impact": "MED", "direction": "NEG" }, { "driver": "Dividend growth track record supporting investor base", "impact": "LOW", "direction": "POS" }, { "driver": "Foreign exchange headwinds from strong USD", "impact": "MED", "direction": "NEG" }, { "driver": "Medical & fluid solutions segment providing defensive growth", "impact": "MED", "direction": "POS" } ], "method_notes": "Blended EV/EBITDA and forward P/E approach. Snapshot gross margin (14%) appears anomalous vs historical (~55%); used snapshot values per rules but normalized EBIT margin assumption at 25% for forward modeling. At ~27x trailing P/E and PEG >5x, valuation looks full relative to low-single-digit growth. 12M base target implies ~3.8% return, within HOLD band. Probability-weighted scenario value ~$282, consistent with modest upside. Not investment advice.", "current_price": 274.57, "recommendation": "HOLD", "thesis_bullets": [ "Quality industrial compounder with 59+ year dividend growth streak", "Elevated PEG ratio of 5.7x signals limited near-term growth for valuation", "Revenue roughly flat YoY while EPS grew ~5% on margin discipline", "Significant debt load (~$2B) from acquisitions limits balance sheet flexibility", "Valuation at ~27x trailing P/E appears full given low-single-digit growth" ], "target_price_6m": 280, "target_price_12m": 285 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "anthropic", "webSearch": { "enabled": false, "maxToolCalls": 2, "disabledReason": null }, "pauseTurns": 0, "stopReason": "end_turn" }, "sanityIssues": [] }, "latencyMs": 36105, "createdAt": "2026-04-09T05:21:28.683Z", "usage": { "inputTokens": 3613, "outputTokens": 1648, "costUsd": 0.059265 } }, { "id": "cmnr14okw05bhp658ch2kejba", "runId": "cmnr14okt05bcp658epo0ohse", "modelId": "deepseek.reasoner", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Nordson Equity Analysis Model\",\n \"as_of\": \"2026-04-08T20:00:00.000Z\",\n \"ticker\": \"NDSN\",\n \"currency\": \"USD\",\n \"current_price\": 274.57,\n \"target_price_6m\": 280.0,\n \"target_price_12m\": 285.0,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.6,\n \"thesis_bullets\": [\n \"Revenue decline poses near-term growth challenges.\",\n \"EPS growth supported by margin improvements and cost controls.\",\n \"High valuation multiples limit significant upside potential.\",\n \"Strong balance sheet and cash flow provide financial stability.\",\n \"Niche market positioning offers long-term growth opportunities.\"\n ],\n \"key_drivers\": [\n {\"driver\": \"Revenue Recovery\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Margin Expansion\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Economic Cyclicality\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n {\"driver\": \"Debt Management\", \"impact\": \"LOW\", \"direction\": \"NEG\"},\n {\"driver\": \"Competitive Pressure\", \"impact\": \"MED\", \"direction\": \"NEG\"},\n {\"driver\": \"Product Innovation\", \"impact\": \"HIGH\", \"direction\": \"POS\"},\n {\"driver\": \"Global Industrial Demand\", \"impact\": \"MED\", \"direction\": \"POS\"},\n {\"driver\": \"Currency Fluctuations\", \"impact\": \"LOW\", \"direction\": \"NEG\"}\n ],\n \"risks\": [\"Continued revenue decline from market softness.\", \"Valuation compression if earnings growth stalls.\", \"Increased competition impacting pricing power.\", \"Economic downturn reducing capital expenditure.\"],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.02,\n \"ebit_margin_target\": 0.165,\n \"wacc\": 0.09,\n \"terminal_multiple\": 17.0\n },\n \"scenarios\": {\n \"bear\": {\"target_price\": 250.0, \"prob\": 0.3, \"notes\": \"Revenue fails to recover with margin pressure.\"},\n \"base\": {\"target_price\": 285.0, \"prob\": 0.5, \"notes\": \"Moderate growth and stable financial performance.\"},\n \"bull\": {\"target_price\": 320.0, \"prob\": 0.2, \"notes\": \"Strong revenue rebound and operational efficiency gains.\"}\n },\n \"method_notes\": \"Based on earnings growth and EV/EBITDA multiple analysis; HOLD due to mixed evidence and limited upside. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:00.000Z", "model": "Nordson Equity Analysis Model", "risks": [ "Continued revenue decline from market softness.", "Valuation compression if earnings growth stalls.", "Increased competition impacting pricing power.", "Economic downturn reducing capital expenditure." ], "ticker": "NDSN", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Moderate growth and stable financial performance.", "target_price": 285 }, "bear": { "prob": 0.3, "notes": "Revenue fails to recover with margin pressure.", "target_price": 250 }, "bull": { "prob": 0.2, "notes": "Strong revenue rebound and operational efficiency gains.", "target_price": 320 } }, "confidence": 0.6, "assumptions": { "wacc": 0.09, "revenue_cagr_3y": 0.02, "terminal_multiple": 17, "ebit_margin_target": 0.165 }, "key_drivers": [ { "driver": "Revenue Recovery", "impact": "MED", "direction": "POS" }, { "driver": "Margin Expansion", "impact": "HIGH", "direction": "POS" }, { "driver": "Economic Cyclicality", "impact": "MED", "direction": "NEG" }, { "driver": "Debt Management", "impact": "LOW", "direction": "NEG" }, { "driver": "Competitive Pressure", "impact": "MED", "direction": "NEG" }, { "driver": "Product Innovation", "impact": "HIGH", "direction": "POS" }, { "driver": "Global Industrial Demand", "impact": "MED", "direction": "POS" }, { "driver": "Currency Fluctuations", "impact": "LOW", "direction": "NEG" } ], "method_notes": "Based on earnings growth and EV/EBITDA multiple analysis; HOLD due to mixed evidence and limited upside. Not investment advice.", "current_price": 274.57, "recommendation": "HOLD", "thesis_bullets": [ "Revenue decline poses near-term growth challenges.", "EPS growth supported by margin improvements and cost controls.", "High valuation multiples limit significant upside potential.", "Strong balance sheet and cash flow provide financial stability.", "Niche market positioning offers long-term growth opportunities." ], "target_price_6m": 280, "target_price_12m": 285 }, "errorsJson": { "attempts": [], "providerMeta": { "endpoint": "https://api.deepseek.com/v1/chat/completions", "provider": "deepseek", "webSearch": { "enabled": false, "supported": false }, "responseFormat": "json_object" }, "sanityIssues": [] }, "latencyMs": 351, "createdAt": "2026-04-09T05:21:28.683Z", "usage": { "inputTokens": 2117, "outputTokens": 3644, "costUsd": 0.002123 } }, { "id": "cmnr14okw05bfp6589bqpmart", "runId": "cmnr14okt05bcp658epo0ohse", "modelId": "gemini.3-pro", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"Equity Research AI Analyst\",\n \"as_of\": \"2026-04-08T20:00:00.000Z\",\n \"ticker\": \"NDSN\",\n \"currency\": \"USD\",\n \"current_price\": 274.57,\n \"target_price_6m\": 292.0,\n \"target_price_12m\": 308.0,\n \"recommendation\": \"BUY\",\n \"confidence\": 0.72,\n \"thesis_bullets\": [\n \"Market leader in precision dispensing with high customer switching costs.\",\n \"Strong exposure to secular growth in medical and electronics verticals.\",\n \"Margin expansion potential driven by the NBS Next operating model.\",\n \"Robust free cash flow generation supports consistent dividend growth.\",\n \"Valuation is attractive relative to historical high-quality industrial peers.\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Semiconductor and electronics market recovery\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Medical device manufacturing demand\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"NBS Next efficiency initiatives\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Global industrial production levels\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Strategic M&A integration and performance\",\n \"impact\": \"LOW\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Raw material and labor cost inflation\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n }\n ],\n \"risks\": [\n \"Cyclical downturn in electronics and semiconductor end markets.\",\n \"Supply chain volatility affecting component availability and lead times.\",\n \"Integration risks associated with large-scale acquisitions.\",\n \"Foreign exchange headwinds impacting international revenue translation.\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.055,\n \"ebit_margin_target\": 0.27,\n \"wacc\": 0.085,\n \"terminal_multiple\": 18.5\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 235.0,\n \"prob\": 0.2,\n \"notes\": \"Reflects a prolonged downturn in electronics and failed margin expansion.\"\n },\n \"base\": {\n \"target_price\": 308.0,\n \"prob\": 0.6,\n \"notes\": \"Assumes mid-single digit growth and steady NBS Next execution.\"\n },\n \"bull\": {\n \"target_price\": 350.0,\n \"prob\": 0.2,\n \"notes\": \"Driven by rapid semiconductor recovery and accretive M&A success.\"\n }\n },\n \"method_notes\": \"Valuation based on a 22x forward P/E multiple on projected FY27 earnings. BUY rating reflects an expected 12% total return, supported by structural margin improvements and exposure to high-growth end markets. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:00.000Z", "model": "Equity Research AI Analyst", "risks": [ "Cyclical downturn in electronics and semiconductor end markets.", "Supply chain volatility affecting component availability and lead times.", "Integration risks associated with large-scale acquisitions.", "Foreign exchange headwinds impacting international revenue translation." ], "ticker": "NDSN", "currency": "USD", "scenarios": { "base": { "prob": 0.6, "notes": "Assumes mid-single digit growth and steady NBS Next execution.", "target_price": 308 }, "bear": { "prob": 0.2, "notes": "Reflects a prolonged downturn in electronics and failed margin expansion.", "target_price": 235 }, "bull": { "prob": 0.2, "notes": "Driven by rapid semiconductor recovery and accretive M&A success.", "target_price": 350 } }, "confidence": 0.72, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.055, "terminal_multiple": 18.5, "ebit_margin_target": 0.27 }, "key_drivers": [ { "driver": "Semiconductor and electronics market recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Medical device manufacturing demand", "impact": "MED", "direction": "POS" }, { "driver": "NBS Next efficiency initiatives", "impact": "HIGH", "direction": "POS" }, { "driver": "Global industrial production levels", "impact": "MED", "direction": "POS" }, { "driver": "Strategic M&A integration and performance", "impact": "LOW", "direction": "POS" }, { "driver": "Raw material and labor cost inflation", "impact": "MED", "direction": "NEG" } ], "method_notes": "Valuation based on a 22x forward P/E multiple on projected FY27 earnings. BUY rating reflects an expected 12% total return, supported by structural margin improvements and exposure to high-growth end markets. Not investment advice.", "current_price": 274.57, "recommendation": "BUY", "thesis_bullets": [ "Market leader in precision dispensing with high customer switching costs.", "Strong exposure to secular growth in medical and electronics verticals.", "Margin expansion potential driven by the NBS Next operating model.", "Robust free cash flow generation supports consistent dividend growth.", "Valuation is attractive relative to historical high-quality industrial peers." ], "target_price_6m": 292, "target_price_12m": 308 }, "errorsJson": { "attempts": [], "providerMeta": { "model": "gemini-3-flash-preview", "provider": "gemini", "webSearch": { "used": false, "allowed": false, "enabled": false, "requested": false, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 17279, "createdAt": "2026-04-09T05:21:28.683Z", "usage": { "inputTokens": 2477, "outputTokens": 787, "costUsd": 0.014398 } }, { "id": "cmnr14okw05bdp658cy8tdmiy", "runId": "cmnr14okt05bcp658epo0ohse", "modelId": "openai.gpt-5.4", "status": "SUCCESS", "rawOutput": "{\"model\":\"OpenAI o3\",\"as_of\":\"2026-04-08T20:00:00.000Z\",\"ticker\":\"NDSN\",\"currency\":\"USD\",\"current_price\":274.57,\"target_price_6m\":262,\"target_price_12m\":286,\"recommendation\":\"HOLD\",\"confidence\":0.63,\"thesis_bullets\":[\"Niche dispensing franchises support pricing power and recurring consumables.\",\"Medical and electronics platforms offer secular growth beyond core industrial demand.\",\"Current valuation already discounts much of a cyclical recovery.\",\"Leverage from acquisitions limits flexibility if demand softens.\",\"Cash generation and dividends provide modest downside support.\"],\"key_drivers\":[{\"driver\":\"Electronics test and inspection recovery\",\"impact\":\"HIGH\",\"direction\":\"POS\"},{\"driver\":\"Medical intervention demand\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Adhesive and industrial order normalization\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Aftermarket and consumables mix\",\"impact\":\"LOW\",\"direction\":\"POS\"},{\"driver\":\"Acquisition synergy execution\",\"impact\":\"MED\",\"direction\":\"POS\"},{\"driver\":\"Valuation multiple compression\",\"impact\":\"HIGH\",\"direction\":\"NEG\"},{\"driver\":\"Leverage and interest expense\",\"impact\":\"MED\",\"direction\":\"NEG\"},{\"driver\":\"Global industrial and FX softness\",\"impact\":\"MED\",\"direction\":\"NEG\"}],\"risks\":[\"Industrial recession reduces capex orders\",\"Acquisition integration underdelivers\",\"Electronics recovery is delayed\",\"Margin pressure from unfavorable mix\",\"Higher rates sustain multiple compression\"],\"assumptions\":{\"revenue_cagr_3y\":0.065,\"ebit_margin_target\":0.205,\"wacc\":0.085,\"terminal_multiple\":18},\"scenarios\":{\"bear\":{\"target_price\":225,\"prob\":0.25,\"notes\":\"Demand stays soft and valuation de-rates further.\"},\"base\":{\"target_price\":286,\"prob\":0.5,\"notes\":\"Modest growth, stable margins, and gradual deleveraging.\"},\"bull\":{\"target_price\":335,\"prob\":0.25,\"notes\":\"Electronics rebound and synergies lift earnings faster.\"}},\"method_notes\":\"Blended normalized EV/EBITDA and FCF-yield framework using snapshot quote fields exactly. Snapshot revenueYoY and cash-flow lines appear noisy/inconsistent, so I weighted margins, leverage and valuation more heavily. HOLD matches mixed evidence and limited 12M upside; not investment advice.\"}", "parsedJson": { "as_of": "2026-04-08T20:00:00.000Z", "model": "OpenAI o3", "risks": [ "Industrial recession reduces capex orders", "Acquisition integration underdelivers", "Electronics recovery is delayed", "Margin pressure from unfavorable mix", "Higher rates sustain multiple compression" ], "ticker": "NDSN", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Modest growth, stable margins, and gradual deleveraging.", "target_price": 286 }, "bear": { "prob": 0.25, "notes": "Demand stays soft and valuation de-rates further.", "target_price": 225 }, "bull": { "prob": 0.25, "notes": "Electronics rebound and synergies lift earnings faster.", "target_price": 335 } }, "confidence": 0.63, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.065, "terminal_multiple": 18, "ebit_margin_target": 0.205 }, "key_drivers": [ { "driver": "Electronics test and inspection recovery", "impact": "HIGH", "direction": "POS" }, { "driver": "Medical intervention demand", "impact": "MED", "direction": "POS" }, { "driver": "Adhesive and industrial order normalization", "impact": "MED", "direction": "POS" }, { "driver": "Aftermarket and consumables mix", "impact": "LOW", "direction": "POS" }, { "driver": "Acquisition synergy execution", "impact": "MED", "direction": "POS" }, { "driver": "Valuation multiple compression", "impact": "HIGH", "direction": "NEG" }, { "driver": "Leverage and interest expense", "impact": "MED", "direction": "NEG" }, { "driver": "Global industrial and FX softness", "impact": "MED", "direction": "NEG" } ], "method_notes": "Blended normalized EV/EBITDA and FCF-yield framework using snapshot quote fields exactly. Snapshot revenueYoY and cash-flow lines appear noisy/inconsistent, so I weighted margins, leverage and valuation more heavily. HOLD matches mixed evidence and limited 12M upside; not investment advice.", "current_price": 274.57, "recommendation": "HOLD", "thesis_bullets": [ "Niche dispensing franchises support pricing power and recurring consumables.", "Medical and electronics platforms offer secular growth beyond core industrial demand.", "Current valuation already discounts much of a cyclical recovery.", "Leverage from acquisitions limits flexibility if demand softens.", "Cash generation and dividends provide modest downside support." ], "target_price_6m": 262, "target_price_12m": 286 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "openai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "resp_086de5bb0cef055d0069d75baede7c8194a8220afbe3d2404e", "reasoningEffort": "medium", "structuredOutputs": { "used": true, "requested": true, "disabledReason": null } }, "sanityIssues": [] }, "latencyMs": 68465, "createdAt": "2026-04-09T05:21:28.683Z", "usage": { "inputTokens": 2388, "outputTokens": 3486, "costUsd": 0.052983 } }, { "id": "cmnr14okw05bgp658fwcfxzda", "runId": "cmnr14okt05bcp658epo0ohse", "modelId": "xai.grok-4.20-reasoning", "status": "SUCCESS", "rawOutput": "{\n \"model\": \"AI Fundamental Valuation Model\",\n \"as_of\": \"2026-04-08T20:00:00.000Z\",\n \"ticker\": \"NDSN\",\n \"currency\": \"USD\",\n \"current_price\": 274.57,\n \"target_price_6m\": 280,\n \"target_price_12m\": 285,\n \"recommendation\": \"HOLD\",\n \"confidence\": 0.62,\n \"thesis_bullets\": [\n \"Dominant position in adhesive dispensing equipment\",\n \"Recent revenue decline raises cyclical concerns\",\n \"Strong FCF supports innovation and shareholder returns\",\n \"Premium valuation with PEG over 5x limits upside\",\n \"Automation trends offer long-term growth potential\"\n ],\n \"key_drivers\": [\n {\n \"driver\": \"Automation and dispensing demand\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Cyclical industrial end-markets\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Margin expansion initiatives\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Acquisition integration\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"Foreign exchange volatility\",\n \"impact\": \"MED\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"New product innovation\",\n \"impact\": \"HIGH\",\n \"direction\": \"POS\"\n },\n {\n \"driver\": \"High valuation multiple\",\n \"impact\": \"HIGH\",\n \"direction\": \"NEG\"\n },\n {\n \"driver\": \"Consistent free cash flow\",\n \"impact\": \"MED\",\n \"direction\": \"POS\"\n }\n ],\n \"risks\": [\n \"Prolonged slowdown in key industrial sectors\",\n \"Challenges integrating recent acquisitions\",\n \"Intense competition in precision tech\",\n \"Customer capex sensitivity to rates\",\n \"Supply chain and inflation pressures\"\n ],\n \"assumptions\": {\n \"revenue_cagr_3y\": 0.055,\n \"ebit_margin_target\": 0.2,\n \"wacc\": 0.085,\n \"terminal_multiple\": 19\n },\n \"scenarios\": {\n \"bear\": {\n \"target_price\": 230,\n \"prob\": 0.35,\n \"notes\": \"Deeper cyclical downturn and margin compression.\"\n },\n \"base\": {\n \"target_price\": 285,\n \"prob\": 0.5,\n \"notes\": \"Stable recovery with maintained valuation.\"\n },\n \"bull\": {\n \"target_price\": 330,\n \"prob\": 0.15,\n \"notes\": \"Accelerated automation adoption drives growth.\"\n }\n },\n \"method_notes\": \"Bottom-up DCF using 5.5% revenue CAGR, 20% EBIT margin, 8.5% WACC and 19x terminal EV/EBIT. Mixed cyclical signals and premium valuation support HOLD. Not investment advice.\"\n}", "parsedJson": { "as_of": "2026-04-08T20:00:00.000Z", "model": "AI Fundamental Valuation Model", "risks": [ "Prolonged slowdown in key industrial sectors", "Challenges integrating recent acquisitions", "Intense competition in precision tech", "Customer capex sensitivity to rates", "Supply chain and inflation pressures" ], "ticker": "NDSN", "currency": "USD", "scenarios": { "base": { "prob": 0.5, "notes": "Stable recovery with maintained valuation.", "target_price": 285 }, "bear": { "prob": 0.35, "notes": "Deeper cyclical downturn and margin compression.", "target_price": 230 }, "bull": { "prob": 0.15, "notes": "Accelerated automation adoption drives growth.", "target_price": 330 } }, "confidence": 0.62, "assumptions": { "wacc": 0.085, "revenue_cagr_3y": 0.055, "terminal_multiple": 19, "ebit_margin_target": 0.2 }, "key_drivers": [ { "driver": "Automation and dispensing demand", "impact": "HIGH", "direction": "POS" }, { "driver": "Cyclical industrial end-markets", "impact": "HIGH", "direction": "NEG" }, { "driver": "Margin expansion initiatives", "impact": "MED", "direction": "POS" }, { "driver": "Acquisition integration", "impact": "MED", "direction": "POS" }, { "driver": "Foreign exchange volatility", "impact": "MED", "direction": "NEG" }, { "driver": "New product innovation", "impact": "HIGH", "direction": "POS" }, { "driver": "High valuation multiple", "impact": "HIGH", "direction": "NEG" }, { "driver": "Consistent free cash flow", "impact": "MED", "direction": "POS" } ], "method_notes": "Bottom-up DCF using 5.5% revenue CAGR, 20% EBIT margin, 8.5% WACC and 19x terminal EV/EBIT. Mixed cyclical signals and premium valuation support HOLD. Not investment advice.", "current_price": 274.57, "recommendation": "HOLD", "thesis_bullets": [ "Dominant position in adhesive dispensing equipment", "Recent revenue decline raises cyclical concerns", "Strong FCF supports innovation and shareholder returns", "Premium valuation with PEG over 5x limits upside", "Automation trends offer long-term growth potential" ], "target_price_6m": 280, "target_price_12m": 285 }, "errorsJson": { "attempts": [], "providerMeta": { "provider": "xai", "webSearch": { "used": false, "enabled": false, "sources": [], "maxToolCalls": 2 }, "responseId": "d87fc487-3106-9bab-a37a-6deb88f95079", "usedFallbackChatCompletions": false }, "sanityIssues": [] }, "latencyMs": 18402, "createdAt": "2026-04-09T05:21:28.683Z", "usage": { "inputTokens": 2728, "outputTokens": 3133, "costUsd": 0.055179 } } ] } }